Globus Medical (GMED) Misses Q1 EPS by 7c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Globus Medical (GMED) PT Lowered to $78 at Oppenheimer
May 9, 2025 10:21 AM EDTOppenheimer analyst Steven Lichtman lowered the price target on Globus Medical (NYSE: GMED) to $78.00 (from $90.00) while maintaining a Perform rating.
The analyst commented, "Globus Medical's 1Q25 sales of $598.1 (-0.8% constant currency) missed our/Street's ~$630.1/$626M estimates. Musculoskeletal was softer on several factors including timing... More
